Moreover, mutation of isocitrate dehydrogenase 1 (IDH1) occurs frequently, which results in accumulation of the metabolic byproduct 2-hydroxy-glutarate (2-HG) in glioma. This evidence concerns the gene IDH1 and central nervous system cancer.